Timing, Not Talent: The Investor Clock Founders Cannot See

Founders spend their energy on the parts of a raise they can see, the deck, the story, the numbers, and rarely ask a duller question: is this investor structurally able to write a cheque this quarter? Judging the asset produces a list of plausible counterparties, but who can actually act is separate, and has little to do with quality: who has a live mandate, who can move this quarter. Founders skip that question and read the result as a verdict on the company.

How Fund Lifecycles Decide Yes and No

A fund raises capital in a given year, its vintage, and runs for roughly ten years. Inside that sits a shorter investment period, typically three to five years, during which it can make new investments at all. The manager holds back a third to a half of committed capital in reserve for follow-ons.

Early on, a fund can take real risk on an unproven company because it has years of reserves left. By mid-life, your company is assessed against the existing portfolio rather than its own merits. Late in a fund’s life, the investment period may have closed, and a partner can rate your company highly with no way to buy in.

A firm announcing a new fund isn’t one that can write you a cheque; it’s starting a process that may take most of a year to close, and the old fund’s constraints apply until then. Founders read it as a green light; it’s the opposite. Fund timing explains why a good company gets a no, not why a weak one becomes a yes.

Why Record Capital Doesn’t Mean Available Capital

Venture fundraising has slowed sharply: just $45bn was raised across 376 funds in the first nine months of 2025, well down on the 2022 peak, per PitchBook data. Dry powder keeps climbing, driven by capital raised in 2022 and 2023 that hasn’t been deployed. Available and deployed are different things, and a fund sitting on capital for two years has already shown it’s in no hurry.

Management fees accrue whether or not capital is deployed, so there’s little pressure to invest, and the two mistakes aren’t symmetrical: a bad investment shows up fast with a name attached, a missed one surfaces years later and belongs to nobody. Staying engaged without committing is the rational move, an incentive that rewards deliberation, not persuasion. Funds raised in 2022-23 are moving through their investment periods now, and undeployed capital against a closing window forces activity, arguing for raising sooner.

The Clock You Actually Control

The investor’s clock is one you can’t move. Your own clock decides whether any of this matters: runway measured honestly, margin at current volume, and where your trajectory crosses the point you must raise rather than choose to.

The timing problem is the gap between when you must raise and when investors can act. A founder who must raise by March runs a different process than one who’d like to raise sometime next year; the first can be selective, the second usually finds out they can’t. AI has widened that gap: build cycles have compressed, so companies need capital sooner, while fund structures move at the same pace they did a decade ago.

Knowing the Buyer Before You Need the Buyer

Nobody volunteers, in a pitch, that a fund is between vintages or that a partner already has troubled companies. You get a polite no and spend three months learning what a coffee chat would have told you a year earlier.

Founders treat investor contact as belonging to a raise, when it belongs to the eighteen months before one. Track your counterparty universe continuously, so the work is already done when a process launches. People say more when nothing is at stake: an investor may admit, over coffee, that they’re not doing anything new until the next fund closes.

Make contact when you want nothing, so the first meeting isn’t the first ask. Ask what investors need rather than telling them what you have. Update on a rhythm, not on need; a short quarterly note builds a record of delivering on what you said. This is coverage, not networking.

Aligning the Two Clocks

Talent, product, and story matter, but no investor sees them in isolation. They see them through the lens of where the fund sits in its life and what it already owns. You can’t change that, but you can know your numbers well enough to see the gap coming, and know the people well enough that the answer takes a conversation, not a quarter. The question isn’t only who to pitch, but who can say yes at your stage.

What happens next depends on whether the company survives diligence: the regulatory position, the cap table, the governance, and whether the founder and fund want the same outcome.

Bio: Michelle Luan is an Investment Banking Associate in M&A and a Senior Executive, specializing in risk evaluation across technology-enabled businesses. She works with founders to refine strategy, prepare for fundraising, and de-risk their path to capital. She has advised on large capital raises and M&A transactions (c. $500m–$5bn) for companies operating in fintech infrastructure, digital platforms, data-driven mobility, and other technology-led businesses.

The views expressed are the author’s own and drawn from general professional experience. They do not represent any current or former employer, and no confidential or client-specific information is referenced.

Sources: